IRDiRC perspectives on the application of digital biomarkers in therapeutic development for rare diseases
Publication date
2025-04
Authors
Krishna, Rajesh
Jonker, Anneliene H.
Morel, Thomas
Sakushima, Ken
Pasmooij, A. M.G.
O'Connor, Daniel
Editors
Advisors
Supervisors
Document Type
Editorial
Metadata
Show full item recordCollections
License
cc_by_nc
Abstract
New approaches are needed to streamline clinical trials of drugs for patients with rare diseases. Digital biomarkers offer one such approach, but several challenges must be addressed to realize their potential.
Keywords
Taverne
Citation
Krishna, R, Jonker, A H, Morel, T, Sakushima, K, Pasmooij, A M G & O'Connor, D 2025, 'IRDiRC perspectives on the application of digital biomarkers in therapeutic development for rare diseases', Nature Reviews Drug Discovery, vol. 24, no. 4, pp. 233-234. https://doi.org/10.1038/d41573-024-00196-z